Prosensa's IPO

Prosensa raised a round of funding on June 28, 2013. Investors include Public.

Prosensa is a biotechnology company focused on the discovery, development and commercialization of RNA-modulating therapeutics. The company targets genetic disorders with a large unmet medical need, w…

Articles about Prosensa's IPO: